Alternative Cancer Treatment
NYC court boots Texas woman's talc/cancer lawsuit against J&J; Using baby powder on a plane not strong enough connection - Legal News Line
NEW YORK (Legal Newsline) – The New York Supreme Court will not be hearing a Texas woman's case against New Jersey-based Johnson & Johnson ...
Woman who was diagnosed with blood cancer at 23 reveals how she became cancer-free in four months - Daily Mail
Sophie Trew, 28, from Walthamstow, says being diagnosed with blood cancer at 23 left her feeling isolated and dispirited there was no treatment beyond ...
Conners Clinic, a Top St Paul MN Alternative Cancer Treatment Clinic in Lake Elmo Announces New Website - Press Release - Digital Journal
Conners Clinic is dedicated to helping patients find solace in a supportive environment conducive to healing. Lake Elmo, MN - There is growing evidence that ...
Cold probe promises cheaper treatment for breast cancer - Futurity: Research News
A tissue-freezing probe could make breast cancer treatments affordable and available to women in low-income and low-resource countries.
Unpacking the Proposed Radiation Oncology Bundled Payment Model - Xtelligent Healthcare Media
July 17, 2019 - On July 10, 2019, CMS proposed a mandatory radiation oncology bundled payment model that aims to improve the quality of care for cancer ...
The green rush for high-quality CBD products - Health Europa
Green Brothers aims to be a global actor in the pharma-cannabis industry by spreading standards of high-quality CBD products worldwide.
Lifting the Burden: How the Raymond Foundation Helps to Support Caregivers - Curetoday.com
Gastrointestinal (GI) cancers remain a serious issue and places a major burden on both the patient and their caregiver.
Atossa Genetics Provides Information on FDA Expanded Access Policy and Requests - GlobeNewswire
SEATTLE, July 17, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (Nasdaq:ATOS), a clinical-stage biopharmaceutical company developing novel ...
Questions over the Neil Woodford stock valued at £393m despite huge losses and no revenues - Evening Standard
It's been 45 days since Neil Woodford pulled up the drawbridge on his flagship Equity Income fund, blocking thousands of people from their savings. As the ...
NICE U-turn for Kisqali in breast cancer - PharmaTimes
The National Institute of Health and Care Excellence (NICE) has recommended Novartis' Kisqali (ribociclib) for use on the NHS in combination with fulvestrant, ...
FDA Approves Merck's RECARBRIO™ For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available - BioSpace
KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and ...
FDA Approves Merck's RECARBRIO™ For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available - BioSpace
KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and ...
FDA Approves Merck's RECARBRIO™ For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available - BioSpace
KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and ...
News - Further advanced breast cancer drug combo available on CDF - OnMedica
Another drug combination for women with advanced breast cancer is set to become available on the Cancer Drugs Fund (CDF) after being given the green light ...
Interventional Oncology Market Segmentation Detailed Study with Forecast to 2025 - The Market Plan
TMR Research delivers incisive insights into emerging regions in its latest report titled, “ Interventional Oncology Market – Global Industry Analysis, Size, Share, ...
Interventional Oncology Market Detailed Study Analysis with Forecast by 2025 - Financial Planning
TMR Research delivers incisive insights into emerging regions in its latest report titled, “ Interventional Oncology Market – Global Industry Analysis, Size, Share, ...
Breast cancer patients to have further NICE-approved drug combination option on Cancer Drugs Fund - NICE
The draft guidance recommends ribociclib (also called Kisqali and made by Novartis) used with fulvestrant as an option for people with hormone ...
Kisqali gains positive NICE recommendation after previous rejection - The Pharma Letter
There was positive news for Swiss pharma giant Novartis (NOVN: VX), with the UK medicines cost-effectiveness watchdog reversing an earlier negative decision ...
Bowel cancer: Can this 3-drug combo offer an alternative to chemo? - - Global Village space
Bowel cancer is a general term for cancer that begins in the large intestine. Depending on where cancer starts, it is sometimes called.
Liquid Biopsy Market 2019 – Expected to Accelerate the Growth of the Industries Forecast 2019-2026 - MENAFN.COM
Global Liquid Biopsy Market Analysis According to Verified Market Research, the Global Liquid Biopsy Market was valued at USD 691.6 Million in 2018 and is ...
